Cna Financial Corp Maxcyte, Inc. Transaction History

Cna Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.59 - $6.81 $172,226 - $326,702	-47,974 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$5.26 - $10.84 $62,746 - $129,310	-11,929 Reduced 19.91%	47,974 $335,000
Q4 2021 Feb 11, 2022	BUY	$8.87 - $12.94 $326,770 - $476,709	36,840 Added 159.74%	59,903 $610,000
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $281,599 - $396,683	23,063 New	23,063 $282,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.